NextGen Sciences, Berg Diagnostics
Neal Siegel, Glenn Barney, Hiroshi Saito, Jay Moyes, Michael Marletta, Richard Lerner
In about a month, the company plans to offer four assays targeted to neurodegenerative disease and heart disease, its CEO said.
The assays will be used by the drug company for preclinical and clinical studies.
Thermo Fisher's BRIMS Center is collaborating with NextGen Sciences to improve that company's suite of biomarker services.
The sale, for undisclosed cash and royalties, completes NextGen's realignment toward biomarker services.
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.